Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure

被引:57
作者
Srivastava, PK [1 ]
Sharma, VK [1 ]
Kalonia, DS [1 ]
Grant, DF [1 ]
机构
[1] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA
关键词
epoxide hydrolase; phosphatase; polymorphism; SNP; stability; dimer; monomer;
D O I
10.1016/j.abb.2004.05.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human soluble epoxide hydrolase (hsEH) has been shown to play a role in regulating blood pressure and inflammation. HsEH consists of an N-terminal phosphatase and a C-terminal epoxide hydrolase domain. In the present study, we examined the effects of polymorphisms in the hsEH gene on phosphatase activity, enzyme stability, and protein quaternary structure. The results showed that mutants Lys55Arg, Arg103Cys, Cys154Tyr, Arg287Gln, and the Arg103Cys/Arg287Gln (double mutant) have significantly lower phosphatase activity compared to the most frequent allele (MFA) of hsEH. In addition, the Lys55Arg, Arg103Cys, Cys154Tyr, Arg287Gln, and the double mutant have significantly lower k(cat)/K-m values. The stabilities at 37 degreesC of purified Arg287Gln and Arg103Cys/Arg287Gln mutants were also significantly reduced compared to the MFA. HPLC size-exclusion studies showed that the MFA exists predominantly as a dimer. However, the Arg287Gln and Arg103Cys/Arg287Gln mutants show increased concentration of the monomer. We conclude that the Arg287Gln polymorphism disrupts putative intra- and inter-monomeric salt-bridges responsible for dimerization. (C) 2004 Published by Elsevier Inc.
引用
收藏
页码:164 / 169
页数:6
相关论文
共 22 条
[1]  
ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
[2]   THE EFFECT OF PH AND TEMPERATURE ON THE SELF-ASSOCIATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AS STUDIED BY EQUILIBRIUM SEDIMENTATION [J].
ADVANT, SJ ;
BRASWELL, EH ;
KUMAR, CV ;
KALONIA, DS .
PHARMACEUTICAL RESEARCH, 1995, 12 (05) :637-641
[3]   Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase [J].
Argiriadi, MA ;
Morisseau, C ;
Hammock, BD ;
Christianson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10637-10642
[4]   GENE EVOLUTION OF EPOXIDE HYDROLASES AND RECOMMENDED NOMENCLATURE [J].
BEETHAM, JK ;
GRANT, D ;
ARAND, M ;
GARBARINO, J ;
KIYOSUE, T ;
PINOT, F ;
OESCH, F ;
BELKNAP, WR ;
SHINOZAKI, K ;
HAMMOCK, BD .
DNA AND CELL BIOLOGY, 1995, 14 (01) :61-71
[5]   CDNA CLONING AND EXPRESSION OF A SOLUBLE EPOXIDE HYDROLASE FROM HUMAN LIVER [J].
BEETHAM, JK ;
TIAN, TG ;
HAMMOCK, BD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (01) :197-201
[6]   IMPROVED RADIOLABELED SUBSTRATES FOR SOLUBLE EPOXIDE HYDROLASE [J].
BORHAN, B ;
MEBRAHTU, T ;
NAZARIAN, S ;
KURTH, MJ ;
HAMMOCK, BD .
ANALYTICAL BIOCHEMISTRY, 1995, 231 (01) :188-200
[7]   Overexpression of C-terminal Src kinase blocks 14,15-epoxyeicosatrienoic acid-induced tyrosine phosphorylation and mitogenesis [J].
Chen, JR ;
Capdevila, J ;
Harris, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13789-13792
[8]   The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase [J].
Cronin, A ;
Mowbray, S ;
Dürk, H ;
Homburg, S ;
Fleming, I ;
Fisslthaler, B ;
Oesch, F ;
Arand, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1552-1557
[9]   Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation [J].
Davis, BB ;
Thompson, DA ;
Howard, LL ;
Morisseau, C ;
Hammock, BD ;
Weiss, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2222-2227
[10]   Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects - The Coronary Artery Risk Development in Young Adults (CARDIA) study [J].
Fornage, M ;
Boerwinkle, E ;
Doris, PA ;
Jacobs, D ;
Liu, K ;
Wong, ND .
CIRCULATION, 2004, 109 (03) :335-339